Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited‐stage small‐cell lung cancer-Reference-Cited by-同舟云学术

Pathologic responses to neoadjuvant chemoimmunotherapy in primary limited‐stage small‐cell lung cancer

Published:2022-10-08 Issue:22 Volume:13 Page:3208-3216
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thoracic Cancer

Author:

Lu Meng¹²^ORCID,Zhang Ran¹,Qi Li‐sha³,Wang Ya‐lei³,Sun Xiao‐xuan¹,You Jian¹²

Affiliation:

1. Department of Thoracic Oncology Tianjin Cancer Hospital Airport Hospital, National Clinical Research Center for Cancer Tianjin China

2. Department of Pulmonary Oncology Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Tianjin China

3. Department of Pathology Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer Tianjin China

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.14679

Reference30 articles.

1. Lung Cancer Statistics

2. Small‐cell lung cancer: management and novelties;Abdelhamid K;Rev Med Suisse,2020

3. Survival of patients with small cell lung cancer undergoing lung resection in England, 1998–2009

4. Bolstering the Case for Lobectomy in Stages I, II, and IIIA Small-Cell Lung Cancer Using the National Cancer Data Base

5. The role of immunotherapy in small cell lung cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Auranofin inhibition of thioredoxin reductase sensitizes lung neuroendocrine tumor cells (NETs) and small cell lung cancer (SCLC) cells to sorafenib as well as inhibiting SCLC xenograft growth;Cancer Biology & Therapy;2024-07-25

2. Multi-dimensional characterization of immunological profiles in small cell lung cancer uncovers clinically relevant immune subtypes with distinct prognoses and therapeutic vulnerabilities;Pharmacological Research;2023-08

3. A multicenter, single-arm, open study of neoadjuvant or conversion atezolizumab in combination with chemotherapy in resectable small cell lung cancer (Cohort Study);International Journal of Surgery;2023-07-07

4. Auranofin Inhibition of Thioredoxin Reductase Sensitizes Lung Neuroendocrine Tumor Cells (NETs) and Small Cell Lung Cancer (SCLC) Cells to Sorafenib as well as Inhibiting SCLC Xenograft Growth;2023-05-09